Who Owns ONCOLYTICS BIOTECH INC (ONCY)? -- Institutional Holders (2026-03-31)
75 institutions reported holding $2.6M of ONCOLYTICS BIOTECH INC (ONCY) in SEC 13F filings for 2026-03-31. Largest institutional holders: RENAISSANCE TECHNOLOGIES LLC ($607,603), Sandbox Financial Partners, LLC ($339,520), SEEDS INVESTOR LLC ($263,472), TOCQUEVILLE ASSET MANAGEMENT L.P. ($126,471), Everhart Financial Group, Inc. ($117,271). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $607,603 | 715,838 | New |
| 2 | Sandbox Financial Partners, LLC | $339,520 | 400,000 | New |
| 3 | SEEDS INVESTOR LLC | $263,472 | 258,306 | Hold |
| 4 | TOCQUEVILLE ASSET MANAGEMENT L.P. | $126,471 | 149,000 | Added |
| 5 | Everhart Financial Group, Inc. | $117,271 | 138,161 | New |
| 6 | XTX Topco Ltd | $93,163 | 109,758 | Added |
| 7 | DOLIVER ADVISORS, LP | $84,880 | 100,000 | New |
| 8 | FRANKLIN RESOURCES INC | $71,307 | 69,842 | Hold |
| 9 | LPL Financial LLC | $66,971 | 78,901 | Added |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $56,818 | 66,939 | Hold |
| 11 | CIBC WORLD MARKET INC. | $51,258 | 60,303 | Trimmed |
| 12 | PFG Investments, LLC | $44,902 | 52,900 | Added |
| 13 | JANE STREET GROUP, LLC | $43,265 | 42,400 | Added |
| 14 | UBS Group AG | $42,925 | 50,559 | Added |
| 15 | HEADINVEST, LLC | $37,941 | 44,700 | Hold |
| 16 | BANK OF MONTREAL /CAN/ | $37,758 | 44,484 | Added |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $35,075 | 41,323 | New |
| 18 | Ball & Co Wealth Management Inc. | $32,000 | 38,253 | Hold |
| 19 | Federation des caisses Desjardins du Quebec | $30,988 | 36,499 | Added |
| 20 | COMMONWEALTH EQUITY SERVICES, LLC | $29,800 | 35,114 | Hold |
| 21 | RAYMOND JAMES FINANCIAL INC | $28,648 | 33,751 | Added |
| 22 | SECURITY NATIONAL BANK OF SIOUX CITY IOWA /IA/ | $28,227 | 33,255 | Hold |
| 23 | SeaCrest Wealth Management, LLC | $27,162 | 32,000 | Hold |
| 24 | Vantage Point Financial LLC | $25,247 | 29,744 | Hold |
| 25 | MORGAN STANLEY | $23,755 | 27,987 | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31